A few Aussie rheumatologists might be feeling a little sleepy this morning if they stayed up late to catch the EULAR virtual sessions live. For those of you who are planning to listen to recordings during daylight hours… here are some tweets that might point you to the interesting sessions! #EULAR2021 Opening Plenary Abstract Session […]
A few Aussie rheumatologists might be feeling a little sleepy this morning if they stayed up late to catch the EULAR virtual sessions live.
For those of you who are planning to listen to recordings during daylight hours… here are some tweets that might point you to the interesting sessions!
#EULAR2021 Opening Plenary Abstract Session 🔵 Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in RA: Results from the COVID-19 Global Rheumatology Alliance @rheum_covid presented by @jeffsparks Great international effort!🗺️ > LA pic.twitter.com/i5vCS8S8B4
— ARD & RMD Open (@ARD_BMJ) June 2, 2021
#Dementia is ⬇️ing in #RheumatoidArthritis btwn 1980s & now despite theory of NSAIDs being protective for cognitive impairment & they have ⬇️ed over time vs matched pop’n. Maybe due to biological or other factors Olmsted county pop study @RheumNow @eular_org #EULAR2021 OP0216 pic.twitter.com/qTWDtSfPt0
— Janet Pope (@Janetbirdope) June 3, 2021
#Eular2021: Is AS & nr-AxSpA the same disease? The current consensus is that they are the two ends of the spectrum — same disease! @RheumNow pic.twitter.com/r0fTtp3Uip
— Meral K. El Ramahi, MD (@MeralElRamahiMD) June 2, 2021
Andrew Ostor @AbbVie symposium @eular_org presented HZ vaccines are safe in RA pts with #JAKi but with Recombinant HZ vaccine humeral response – 75% in RA pts in JAKi vs 100% controls. So should we hold JAKi with Shringix & if so for 1 or 2 wks? #EULAR2021 @RheumNow pic.twitter.com/wVOFMa9fLm
— Janet Pope (@Janetbirdope) June 2, 2021
Dr Mekinian presents data showing TCZ and TNFi appear equally effective in TAK, complete response 66% vs 70% at 6 months @RheumNow #EULAR2021 Abstr#OP0068
— Richard Conway (@RichardPAConway) June 2, 2021
OP0010 at #EULAR2021. FLORA trial: Fecal microbiota transplant as add-on Rx to MTX. Small trial showing time-to-event curves show inferiority to sham but good safety. Fascinating concept exploring gut-joint interaction. @RheumNow. pic.twitter.com/BIOmA5z6vK
— Eric Dein (@ejdein1) June 2, 2021
To clot or NOT? Real world data usually show no ⬆️ VTE in RA with #Jaki compares to other advanced therapies. Diff from high CV risk pts in Oral Surveillance where Tofacitinib had higher VTE vs TNFi @AbbVie symposium @eular_org #EULAR2021 @RheumNow Hard to reconcile diff risk. pic.twitter.com/AWY2zZPSIb
— Janet Pope (@Janetbirdope) June 2, 2021
The counterintuitive fecal transplant of gut micobiome data in PsA gave worse outcomes…Is it all a crock of SH^T or maybe we don’t understand which good bacteria and in what ratio are needed and how much time to change immune downstream effects. @eular_org @RheumNow #EULAR2021 https://t.co/PrdZs1WUu8
— Janet Pope (@Janetbirdope) June 3, 2021
@EricFMorand on LLDAS one of two Aussies giving invited talks in the first session at #EULAR2021 (along with Ranjeny Thomas on tolerising with peptides in RA) – flying the flag!
— David Liew (@drdavidliew) June 2, 2021
🇦🇺🇦🇺🦘 @AusRheum @earlyARA @RheumNow https://t.co/nQjcFxLIBj
